Nitric oxide synthase and reduced arterial tone contribute to arteriovenous malformation

Sci Adv. 2023 May 26;9(21):eade7280. doi: 10.1126/sciadv.ade7280. Epub 2023 May 26.

Abstract

Mechanisms underlying arteriovenous malformations (AVMs) are poorly understood. Using mice with endothelial cell (EC) expression of constitutively active Notch4 (Notch4*EC), we show decreased arteriolar tone in vivo during brain AVM initiation. Reduced vascular tone is a primary effect of Notch4*EC, as isolated pial arteries from asymptomatic mice exhibited reduced pressure-induced arterial tone ex vivo. The nitric oxide (NO) synthase (NOS) inhibitor NG-nitro-l-arginine (L-NNA) corrected vascular tone defects in both assays. L-NNA treatment or endothelial NOS (eNOS) gene deletion, either globally or specifically in ECs, attenuated AVM initiation, assessed by decreased AVM diameter and delayed time to moribund. Administering nitroxide antioxidant 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl also attenuated AVM initiation. Increased NOS-dependent production of hydrogen peroxide, but not NO, superoxide, or peroxynitrite was detected in isolated Notch4*EC brain vessels during AVM initiation. Our data suggest that eNOS is involved in Notch4*EC-mediated AVM formation by up-regulating hydrogen peroxide and reducing vascular tone, thereby permitting AVM initiation and progression.

MeSH terms

  • Animals
  • Arteries / metabolism
  • Arteriovenous Malformations*
  • Hydrogen Peroxide* / metabolism
  • Mice
  • Nitric Oxide Synthase / genetics
  • Nitric Oxide Synthase / metabolism
  • Nitric Oxide Synthase Type III*
  • Nitroarginine / pharmacology

Substances

  • Hydrogen Peroxide
  • Nitric Oxide Synthase
  • Nitroarginine
  • Nitric Oxide Synthase Type III